CULT Food Science Portfolio Company Eat Just Receives Additional Singapore Food Agency Approvals for Cultivated Chicken Products

Eat Just’s Good Meat Division to Sell New Types of Cultivated Chicken  Products Including Chicken Breast in Singapore – the World’s Only  Approved Marketplace for Cell-Based Meats 

Vancouver, British Columbia – December 20, 2021 / CNW / – CULT Food Science Corp.  (“CULT” or the “Company”), an innovative investment platform with an exclusive focus on clean,  lab-grown food that is advancing the development of novel technologies to provide a sustainable,  environmental and ethical solution to the global factory farming and aquaculture crises, is pleased  to announce that its San Francisco, California-based portfolio company, Eat Just, Inc. (“Eat Just”  or the “Portfolio Company”) has recently received approval from the Singapore Food Agency  (the “SFA Approval”) to sell new types of cultivated chicken products, including chicken breast,  beginning next year.  

The SFA Approval is aligned with Singapore’s target to produce 30% of its nutritional needs in country by 2030, via the combination of cell-based agriculture and other innovative technologies.  Cell-based proteins are being represented as potentially more sustainable, environmentally  friendly, and scalable than traditional meat products, as large volumes of cell-cultured foods can  be produced using less land and labour. As previously announced, Eat Just's GOOD Meat division  ("GOOD Meat") completed a US$97 million financing, as part of a total US$267 million round,  thereby setting a record for the cultured meat industry.  

Eat Just was founded in 2011 and surpassed a US$1 billion valuation in 2016. Eat Just formed the  GOOD Meat division in 2017 when CULT’s Portfolio Company announced that it was developing  a lab-grown meat product to make chicken nuggets. GOOD Meat produces meat products in a  controlled, sterile environment from a single cell, thereby removing slaughter from the process  and significantly lowering the risk of food-borne illness. The cell-based meat is more safely  produced by being grown in a bioreactor in a fluid primarily containing the simple components  of amino acids, sugar, and salt.  

Further, Eat Just recently announced plans for private tasting sessions of its newly approved  chicken products being hosted at the JW Marriott Hotel Singapore South Beach during the week  of December 20, 2021. CULTs Portfolio Company also provided guidance that its novel cell-based  chicken breast expects to be integrated at various hawker centre stalls in Singapore, including the  renowned Loo’s Hainanese Curry Rice in Tiong Bahru. 

Management Commentary  

“CULT applauds Eat Just’s receipt of additional approvals from the Singapore Food Agency as  continued evidence of its industry leading production, compliance and innovation capabilities. A  core holding of CULT’s investment portfolio, GOOD Meat’s progress further crystalizes CULT as  the most accessible and democratized pure-play platform for cell-based foods and associated IP  and research opportunities,” said Dorian Banks, CEO of CULT.  

About CULT Food Science  

CULT Food Science Corp. is an innovative investment platform with an exclusive focus on clean,  lab-grown food that is advancing the development of novel technologies to provide a sustainable,  environmental, and ethical solution to the global factory farming crisis. The first-of-its-kind in  North America, CULT Food Science aims to provide individual investors with unprecedented  exposure to the most innovative start-up, private or early-stage cultivated meat and cultured  dairy companies around the world.  

Additional information can be found by viewing the Company's website at  www.cultfoodscience.com or its regulatory filings on www.sedar.com.  

On behalf of the Board of Directors of the Company,  

CULT FOOD SCIENCE CORP.  

"Dorian Banks"  

Dorian Banks, CEO  

For further information:  

Cult Food Science Corp.  

Tel: +1 (604) 687-2038  

Email: hello@cultfoodscience.com 

Forward-Looking Information:  

Information set forth in this news release may involve forward-looking statements. Forward looking statements are statements that relate to future, not past, events. In this context, forward looking statements often address a company's expected future business and financial  performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect",  and "intend", statements that an action or event "may", "might", "could", "should", or "will" be  taken or occur, or other similar expressions. By their nature, forward-looking statements involve  known and unknown risks, uncertainties and other factors which may cause our actual results,  performance or achievements, or other future events, to be materially different from any future  results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include but are not limited to the following risks: those associated with marketing  and sale of securities; the need for additional financing; reliance on key personnel; the potential  for conflicts of interest among certain officers or directors with certain other projects; and the  volatility of common share price and volume. Forward-looking statements are made based on  management's beliefs, estimates and opinions on the date that statements are made and except  as required by law, the Company undertakes no obligation to update forward-looking statements  if these beliefs, estimates and opinions or other circumstances should change. Investors are  cautioned against attributing undue certainty to forward-looking statements. For further 

information on risk, investors are advised to see the Company's MD&A and other disclosure  filings with the regulators which are found at www.sedar.com.